Scientists in Cambridge and Berlin have used a form of gene therapy to increase levels of the so-called “cold shock protein” in the brains of mice, protecting them against the potentially devastating impact of prion disease.
Scientists in Cambridge and Berlin have used a form of gene therapy to increase levels of the so-called “cold shock protein” in the brains of mice, protecting them against the potentially devastating impact of prion disease.
Leave A Comment